Dr. Serena Chen asked...
What do you want colleagues to know about getting involved in advocacy about policy issues?
5 contributors
Highlights
- Physicians have a professional obligation to engage in policy, as their historical reluctance to do so has been detrimental to patient care.
- Effective advocacy combines leading with scientific evidence and data while also powerfully representing the personal stories and experiences of individual patients.
- Advocacy at the state and local levels has proven highly effective in passing meaningful legislation, even when federal change seems difficult.
- Partnering with organizations like ASRM or RESOLVE streamlines the process, allowing physicians to simply provide their expertise and tell the truth.
- Anti-abortion laws defining life at conception directly impact fertility care, creating ethical and practical challenges for IVF and embryo freezing.
Expert Insights
The Professional Imperative for Physician Advocacy
A growing consensus among physician leaders suggests that engagement in policy and advocacy is no longer optional but a core professional responsibility. Historically, the medical community has maintained a distance from political discourse, operating under the belief that science and medicine occupy a separate, ethically superior space. Dr. Deborah Bartz, an OB/GYN, argues this reluctance has been detrimental, leaving physicians without a voice in critical discussions and resulting in suboptimal health policy. "This absence has been harmful to health policy, to our patients, and to the political and legal aspects of health," she states, urging colleagues to get "more skin in the game." This sentiment is echoed by Dr. Serena Chen, a reproductive endocrinologist, who suggests that the challenging legal landscape following the Dobbs decision is partly a consequence of physicians not being present when key laws were crafted. The core message is clear: physicians possess vital credentials, knowledge, and expertise that are essential to shaping sound healthcare legislation.
Leading with Science and Story
Effective physician advocacy hinges on a unique combination of empirical evidence and compelling patient narratives. Dr. Shikha Jain, a hematologist-oncologist, offers a foundational principle: "Lead with science. Make sure you're using evidence to back up your arguments, and try to lead with facts not opinions." This evidence-based approach provides credibility and grounds policy discussions in medical reality. However, data alone is often insufficient. Dr. Debra Houry, an emergency medicine physician, emphasizes that physicians are uniquely positioned to represent not only the data but also "the stories of our patients—many of whom do not advocate for themselves." She advises a bipartisan approach that focuses on the direct impact to health. Dr. Chen provides a powerful clinical example from New Jersey, where an insurance mandate for IVF was written in a way that discriminated against lesbian couples by requiring them to undergo multiple, medically and economically unsound IUI cycles with expensive donor sperm. By presenting the clinical evidence—the low efficacy of IUI with frozen sperm compared to IVF—alongside the story of her patients' fight against discrimination, advocates successfully amended the law. This fusion of scientific rationale and human experience is a physician's most potent advocacy tool.
"It's important to stay bipartisan in approach when possible, focusing on the impact to health." Dr. Debra Houry
The Power of State and Local Action
While federal policy change can seem intractable, experts highlight the significant impact physicians can have at the state and local levels. Both Dr. Molly Moravek and Dr. Chen, both reproductive endocrinologists, note that progress in securing fertility coverage has been achieved state by state after national mandates failed. "As much as I'd love to work at the national level, we're seeing more success state by state," Dr. Moravek observes. Dr. Chen points to a decade of progress in which the number of state mandates for infertility coverage has more than doubled, driven by patient and physician stories. She recounts how a few constituents in New Jersey, including her own patients, initiated a lawsuit that changed the lives of thousands. She also shares the story of Dr. Stephanie Gustin in Nebraska, who, along with competing practices, successfully mobilized against an extreme personhood bill by collecting and presenting patient stories to state representatives. These examples demonstrate that focused, local advocacy can produce tangible legislative victories and protect patient access to care, even in politically challenging environments.
Overcoming Barriers to Engagement
Many physicians feel ill-equipped for policy work, citing a lack of training or a professional culture that encourages neutrality. Dr. Chen pushes back against this notion, stating, "Doctors are often bad at speaking up because we’re trained to be apolitical and neutral." She clarifies that the goal is not to be partisan but to be "involved in the policy process, raising awareness and educating politicians who make healthcare laws but often don’t understand healthcare." Furthermore, she argues that the most difficult part of the journey—becoming a doctor—is already complete, and the skills required for patient advocacy are directly transferable. Physicians need not become lobbyists or legal experts. Organizations like RESOLVE and ASRM provide the necessary infrastructure, drafting bills, meeting with staffers, and arranging testimony. "They tee it up so all I have to do is be myself and tell the truth," Dr. Chen explains, demystifying the process and making it accessible for busy clinicians.
"The hardest part was becoming a doctor—after that, physicians are already skilled advocates." Dr. Serena Chen
The High Stakes of Clinical Silence
The consequences of physician disengagement are increasingly evident in clinical practice, particularly in reproductive health. Dr. Molly Moravek outlines how anti-abortion laws that define life as beginning at conception directly threaten fertility care. Such definitions raise profound ethical and practical dilemmas regarding the freezing of embryos, the use of preimplantation genetic testing, and the management of non-viable embryos, potentially forcing physicians and patients into heartbreaking clinical scenarios. Dr. Chen adds that these threats extend beyond reproductive medicine, citing attempts to revoke FDA approval for mifepristone and misoprostol—drugs essential for managing miscarriages and postpartum hemorrhage. She argues that physicians in states with protected access have an obligation to speak up, as "things that start in red states can affect all of us." The experts agree that while a vocal minority may drive restrictive legislation, a strong majority of the public supports access to treatments like IVF. The problem, as Dr. Chen concludes, is that "the majority is often silent, and doctors are a big part of that silence. If we want to make change, we need to stop being silent."
"Regardless of one's political, religious, or ethical stance on abortion, people need to realize that defining when life begins affects not only abortion laws but also fertility laws." Dr. Molly Moravek
